Biosketch / Results /

Richard Nachtigall

Clinical Professor, Department of Medicine
Medicine

Contact Info

212/355-7667


Osteoporosis Risk Factors and Early Life-style Modifications to Decrease Disease Burden in Women
Nachtigall, Margaret J; Nazem, Taraneh G; Nachtigall, Richard H; Goldstein, Steven R
2013-11-11; 0009-9201,Clinical obstetrics & gynecology - id: 614322, year: 2013 Journal Article

A prospective study of DT56a (Femarelle) for the treatment of postmenopausal vaginal atrophy
Nachtigall, M; Naftolin, F; Nachtigall, R; Yoles, I; Nachtigall, L E
2012-05-07; 1072-3714,Menopause - id: 166537, year: 2011

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women
Nachtigall, Margaret J; Jessel, Rebecca H; Flaumenhaft, Robert; Nachtigall, Richard; Yoles, Israel; Naftolin, Frederick; Nachtigall, Lila E
2012-02-05; 1530-0374,Menopause - id: 129318, year: 2011

Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women
Flaumenhaft, Robert; Nachtigall, Margaret; Lowenstein, Joanna; Nachtigall, Lisa; Nachtigall, Richard; Nachtigall, Lila
2012-02-05; 1530-0374,Menopause - id: 129000, year: 2009

Femarelle (R), a Novel SERM for the Treatment of Menopause. Did Not Affect the Clotting Time of Either Normal or Thrombophilic Postmenopausal Women
Nachtigall, M; Nachtigall, L; Nachtigall, R; Yoles, I; Flaumenhaft, R
2012-02-05; 1072-3714,Menopause - id: 90945, year: 2008